WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

M4Q (R2) is a globally harmonized framework for structuring quality information in medicinal product registration ...

Ulanqab Kema’s growth is underpinned by a multifaceted strategic advantage. Its location in Ulanqab, Inner Mongolia, provides direct access to high-quality raw material inputs and cost-effective ...

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was announced by the FDA in August 2002 to improve and modernize pharmaceutical ...

Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing ...

HUNTSVILLE, ALABAMA / ACCESS Newswire / January 19, 2026 / Curiteva, Inc., a leading privately held, technology-driven manufacturing company, announces the recent 510(k) clearance from the FDA for a n ...

Partnership Leverages Callan JMB's Federal Contract Experience, Cold Chain Infrastructure, and Strategic National Stockpile Relationships to ...

Callan JMB Inc. (NASDAQ: CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, ...

The integration of flexible manufacturing, process intensification, and sustainability is redefining the global supply chain.

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth Mont-Saint-Guibert, Belgium - January 21, 2026, 10:05 pm CET / 4:05 pm ET - Nyxoah SA (Euronext ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.